This drug was suggested right from the beginning.
I would like to know how it compares with the far cheaper and more available HCQ.
Hopefully, HCQ will be found effective for treatment if started early and this expensive drug will be useful for more advanced cases.
New Sermo survey of Covid-19 treaters released yesterday:
*Hydroxychloroquine use in NY has doubled since March 25.
*HCQ continues to grow.
*HCQ and plasma seen as the most successful treatments.
The top treatments that have been used/seen used and reported as very or extremely effective among COVID treaters (N= 1337) include:
46% plasma from recovered patients (n=363); 40% Hydroxychloroquine (n=875); 38% high dose steroids during a cytokine storm (n=556)
- Usage of anti-HIV drugs (e.g. Lopinavir plus Ritonavir), drugs to treat the flu (e.g. Oseltamivir), and plasma from recovered patients remains steady week over week, while use of non-approved drugs (e.g. Remdesivir) decreased slightly.
- Survey: Physicians who treat COVID patients in Italy, Spain, France, and China have higher perceptions of Hydroxychloroquines efficacy vs the US (~50% vs 29%).
- Survey: Italy and France had the highest increase in COVID treaters having prescribed Hydroxychloroquine wave over wave; an increase from 50% to 83% for Italy and an increase from 20% to 50% for France.
“Interesting that those on the front lines currently see Remdesivir as less effective than hydroxychloroquine or even steroids.” - analysis
https://www.sermo.com/press-releases/category/week-of-0413/